{"disease":{"id":"early-and-severe-systemic-sclerosis","name":"early and severe systemic sclerosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00379431","title":"A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"University Hospital, Ghent","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}